Trends in Formulation 2023 eBook
Read the article
Read the ebook
Feature|Articles|October 15, 2023
- Trends in Formulation, October 2023 eBook
- Volume 2023 eBook
- Issue 5
- Pages: 48–49
Welcome to CPHI Barcelona
Author(s)CPHI Content Team
Sherma Ellis Daal, brand director, Pharma at Informa Markets, gives a preview of CPHI Barcelona 2023.
Advertisement
This year’s CPHI heads to Barcelona from October 24–26, 2023 at the Fira de Barcelona. The worldwide event will bring together innovative businesses and thought leaders under one roof.“We are excited to welcome the industry back to the heart of pharma. CPHI Barcelona presents a one-of-a-kind experience this year, merging the best of online and on-site experiences with exhibition, seminars, workshops, and our Event Planner app. There will also be fresh opportunities to forge valuable connections and discover the latest innovations in our vibrant start-up market,” says Sherma Ellis Daal, brand director, Pharma at Informa Markets. The following is an exclusive interview with Daal for Pharmaceutical Technology®.
Read this
About the author
This interview was conducted and prepared by the CPHI Content Team.
Article details
Pharmaceutical Technology
Trends in Formulation eBook
October 2023
Pages: 48–49
Citation
When referring to this article, please cite it as CPHI Content Team. Welcome to CPHI Barcelona. Pharmaceutical Technology Trends in Formulation 2023 eBook. October 2023.
Articles in this issue
almost 3 years ago
Advancing Oral Drug Development Using MIFDalmost 3 years ago
Optimizing the Total Cost of Ownership for APIsalmost 3 years ago
The New Digital Era for Formulation Developmentalmost 3 years ago
Innovative Start-Ups at CPHI Barcelonaalmost 3 years ago
Trends in Formulation for Highly Potent Drugsalmost 3 years ago
The Impact of AI on PharmaAdvertisement
Related to this article
The company is showcasing new development solutions and advanced digital technologies including its new OSD Express and Steriles Express solutions for drug development.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
2
Manufacturing Intelligence: Organoids, Organ-on-a-Chip, and the Trust Gap
3
CPHI Milan: Packaging and Delivery Decisions Must Reflect Real-World Care
4
PharmTech AI Pulse Check: On-Prem vs. Cloud AI
5